Cytokeratin 19 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cytokeratin 19 monoclonal antibodies for research in cell biology and pathology. Cytokeratin 19 monoclonal antibodies are highly effective in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytokeratin 19 is a type of intermediate filament protein that plays a crucial role in maintaining the structural integrity of epithelial cells. Expression patterns of Cytokeratin 19 serve as valuable biomarkers for tumor diagnosis and prognosis. Understanding the function and regulation of Cytokeratin 19 advances knowledge of epithelial cell behavior and disease progression. Researchers worldwide utilize Cytokeratin 19 monoclonal antibodies to investigate cellular structure, cancer development, and therapeutic responses. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization of Cytokeratin 19 in experimental settings. Santa Cruz Biotechnology monoclonal antibodies for Cytokeratin 19 continue to support breakthrough discoveries in cancer research and cellular biology.